Cell therapy is moving from experimental treatment to mainstream clinical practice and reshaping what's possible across oncology, regenerative medicine and chronic disease management. In this episode, we sit down with leading voices in biotech to unpack where the science stands today, the manufacturing and regulatory hurdles still ahead, and what breakthroughs are likely to define the next decade of cell-based treatment.